Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Tufts University School of Dental Medicine, Boston, Massachusetts.
Pain Med. 2019 Nov 1;20(11):2311-2323. doi: 10.1093/pm/pnx143.
This manuscript reviews medical literature published pertaining to the management of chronic pain with medical marijuana therapy (MMJ), with an emphasis on the social, medical, and legal aspects of therapy.
Narrative review of peer-reviewed literature.
The 3rd Symposium on Controlled Substances and Their Alternatives for the Treatment of Pain was held in Boston on February 27, 2016, with a focus on MMJ for the treatment of chronic pain. Invited speakers had diverse backgrounds, including pain management, addiction psychiatry, neurology, and legal authorities. The purpose of this conference and this subsequent narrative review is to provide a medical, legal, and logistical framework for physicians and other health care providers to refer to when considering the initiation of medical marijuana therapy.
The invited speakers each covered a unique aspect of MMJ therapy for the treatment of chronic pain. These presentations highlighted the current data for and against the use of MMJ as a pain therapy. Optimal patient selection and screening, in addition to policy developments, were discussed.
Increasing interest in MMJ for chronic pain underscores a need for primary care and pain physicians to better understand the indications and evidence for its use free from cultural bias. Given a lack of full conclusive clinical utility, continued research is needed to better understand how to best utilize MMJ therapy for the treatment of chronic pain. Policy initiatives, such as enumerated indications, should follow medical science in order to prevent another abused substance epidemic.
本文综述了与医用大麻疗法（MMJ）治疗慢性疼痛相关的医学文献，重点介绍了治疗的社会、医学和法律方面。
同行评议文献的叙述性综述。
2016 年 2 月 27 日在波士顿举行了第三届管制物质及其替代品治疗疼痛研讨会，重点是 MMJ 治疗慢性疼痛。受邀演讲者背景多样，包括疼痛管理、成瘾精神病学、神经病学和法律权威。本次会议和随后的叙述性综述旨在为医生和其他医疗保健提供者提供一个医学、法律和后勤框架，供他们在考虑启动医用大麻疗法时参考。
受邀演讲者每人都涵盖了 MMJ 治疗慢性疼痛的独特方面。这些演讲强调了目前使用 MMJ 作为疼痛治疗的利弊数据。讨论了最佳患者选择和筛选，以及政策发展。
对 MMJ 治疗慢性疼痛的兴趣增加，突出表明初级保健和疼痛医生需要更好地了解其使用的适应症和证据，避免文化偏见。鉴于缺乏完整的临床实用性，需要继续研究以更好地了解如何最好地利用 MMJ 治疗慢性疼痛。政策举措，如列举的适应症，应遵循医学科学，以防止另一种滥用物质的流行。
